Down’s Symptoms Could Be Reversible
Chemistry & Industry Magazine
The discovery of a gene responsible for learning and memory defects in Downs Syndrome means mental retardation may soon be reversible, according to a report in this issue of Chemistry & Industry magazine. The gene was discovered by a group led by William Mobley, director of a new centre for Down s syndrome research at Stanford University, California.
The bottom line is that we have found one gene that we think is very important, says Mobley. And from what we have seen in the lab, the neuronal damage [it causes] is totally reversible. He says that a drug could reverse the effects of the gene and the mental retardation. Theoretically, you can treat Downs at any stage. This means that even patients at a fairly advanced age could be treated, he says. Downs researcher Stylianos Antonarakis of the University of Geneva says that the find is fantastic. We have always thought that there are probably only a few genes involved in mental retardation, so it is feasible that a single gene may be responsible. And it seems perfectly possible to down-regulate that gene using RNAi or other methods, he says.
Alle Nachrichten aus der Kategorie: Life Sciences
Articles and reports from the Life Sciences area deal with applied and basic research into modern biology, chemistry and human medicine.
Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.
In a field where smaller is better, researchers discover the world’s tiniest antibodies
Researchers at the University of Bath in the UK and biopharma company UCB have found a way to produce miniaturised antibodies, opening the way for a potential new class of treatments for…
Researchers create artificial lung to support pre-term babies in distress
An international team led by current and former McMaster University researchers has developed an artificial lung to support pre-term and other newborn babies in respiratory distress. The group has proven…